| dc.contributor.author | Malerbao, María. | |
| dc.date.accessioned | 2021-02-24T11:30:46Z | |
| dc.date.available | 2021-02-24T11:30:46Z | |
| dc.date.issued | 2018-04-01 | |
| dc.identifier.citation | Revista Enfermería Neonatal. Abril 2018;26:16-22 | en_US |
| dc.identifier.issn | 2591-6424 | |
| dc.identifier.uri | https://riu.austral.edu.ar/handle/123456789/1076 | |
| dc.description | Disponible en: https://drive.google.com/file/d/1EI-_nBKjbmL55plyDH8u6QBELc8QqmVo/view | en_US |
| dc.description.abstract | The first part of this article was published in the N° 25
of Enfermería Neonatal, and it addressed the aspects
related to the immunology of human milk (HM),
this being a crucial question that grounds its choice
as the first food option for both term and preterm
infants. The mechanisms of transfer of immunological
factors and the action of them in the microbiota were
detailed. In this second part we present an innovative
strategy in the optimization of the use of HM, such as
the topication of the oropharynx with colostrum. | en_US |
| dc.language.iso | es | en_US |
| dc.publisher | FUNDASAMIN (Fundación para la Salud Materno Infantil) | en_US |
| dc.subject | Human milk | en_US |
| dc.subject | Maternally adquired immunity | en_US |
| dc.subject | Microbiota | en_US |
| dc.subject | Colostrum | en_US |
| dc.title | Uso de calostro como terapia inmunológica en recién nacidos prematuros. Parte II | en_US |
| dc.type | Article | en_US |
